If you are looking for a way to earn some extra money while contributing to medical research, you might be interested in participating in clinical trials. Clinical trials are studies that test new drugs, devices, or treatments on human volunteers. They are essential for advancing medical knowledge and finding better ways to prevent, diagnose, or treat diseases.

However, not all clinical trials are the same. Some may offer more compensation than others, depending on the type and duration of the study, the risks and benefits involved, and the eligibility criteria for participants. In this blog post, we will explore some of the best paying clinical research studies in Miami, Florida, and how you can apply for them.

What are the best paying clinical research studies in Miami?

According to ClinicalTrials.gov, a database of publicly and privately funded clinical studies around the world, there are currently 1,238 active clinical trials in Miami as of March 2024. Of these, 347 are recruiting or not yet recruiting participants, which means you may have a chance to join them if you meet the requirements.

The amount of compensation you can receive from a clinical trial varies widely depending on many factors. Some studies may only reimburse you for travel expenses or provide free medical care, while others may pay you hundreds or thousands of dollars for your time and effort. Generally speaking, the more invasive or risky the study is, the higher the compensation will be.

To give you an idea of what kind of clinical trials are available and how much they pay, we have compiled a list of some of the best paying clinical research studies in Miami based on the information provided by ClinicalTrials.gov. Note that this list is not exhaustive and may change over time as new studies are added or completed. Always check the official website of the study for the most updated and accurate information before applying.

Here are some of the best paying clinical research studies in Miami as of March 2024:

• A Phase 3 Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and Staff (BLAZE-2): This study is testing the safety and effectiveness of two monoclonal antibodies that target the coronavirus that causes COVID-19. The study is looking for nursing home residents and staff who have been exposed to someone with COVID-19 or who have a high risk of exposure. Participants will receive either one of the antibodies or a placebo by intravenous infusion once. The study will last for 24 weeks and participants will be compensated up to $1,200.

• A Study to Evaluate the Safety and Efficacy of CRISPR Therapeutics’ CTX001 in Patients With Severe Sickle Cell Disease: This study is testing a gene therapy that uses CRISPR technology to edit the DNA of blood stem cells to produce healthy red blood cells. The study is looking for adults with severe sickle cell disease who have had at least two vaso-occlusive crises (painful episodes caused by blocked blood vessels) in the past year. Participants will undergo a bone marrow transplant with their own edited stem cells and receive supportive care for up to two years. The study will last for 15 years and participants will be compensated up to $75,000.

• A Phase 2 Study of MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder (PTSD) in Veterans: This study is testing the safety and effectiveness of MDMA (also known as ecstasy or Molly) combined with psychotherapy for treating PTSD in veterans. The study is looking for veterans with chronic PTSD who have not responded well to other treatments. Participants will receive either MDMA or a placebo along with 12 sessions of psychotherapy over 18 weeks. The study will last for one year and participants will be compensated up to $10,000.